GeneCode is a private pharmaceutical development company focused on the development of disease-modifying therapeutics to combat neurodegeneration. The GDNF Mimetics platform leverages the disease-modifying properties of GDNF to small molecules with drug-like properties. R&D-wise, GeneCode has remarkably improved the properties of the identified hits, making them more active and effective, drug-like and better show their ability to combat neurodegeneration in Parkinson´s disease (PD).
Company Details
- Employees
- 5
- Founded
- -
- Address
- Ahtri 8, Tallinn,harjumaa 10151,estonia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.genecode.com
- HQ
- Tallinn, Harjumaa
Genecode Questions
Genecode's website is http://www.genecode.com
Genecode's LinkedIn profile is https://ee.linkedin.com/company/genecode
Genecode has
5 employees.
View email and phone details for 5
employees at Genecode.
Genecode's industry is
Biotechnology Research
Genecode's top competitors are
Glycanostics,
Antegenes,
Chemestmed,
Nanordica Medical,
Gearbox Biosciences,
Zipprime Oü,
Arctic Therapeutics,
Vectiopep,
Elcogen,
Asgard Therapeutics.
Genecode's categories are Biotechnology Research
Genecode's founding year is 1998
